| 1 |
Lim YC. An analysis of articles published in the Journal of Korean Society for Clinical Pharmacology and Therapeutics. J Korean Soc Clin Pharmacol Ther, 2012;20(1):34-41. (Korean)/
|
|
| 2 |
Lee, H. (2012). Equivalence margin of the biosimilar product. Journal of Korean Society for Clinical Pharmacology and Therapeutics, 20, 17-33./
|
|
| 3 |
Lee, S. H., Choe, B. I., Kim, C. M., & Kim, K. S. (2009). A survey on perception of clinical trial of pharmaceuticals and informed consent in Korea. Journal of Korean Society for Clinical Pharmacology and Therapeutics, 17 (1), 72-92./
|
|
| 4 |
Park HJ, Oh WY, Na HS, et al., Guidance for the clinical trials evaluation for hypertension. Kor J Clin Pharmacol Ther 2009; 17(2): 124-38./
|
|
| 5 |
정순옥, 권수경, 최인영, "임상시험정보시스템 현황분석과 적용방안 모색", 대한임상약리학회지, 제16권, 제2호, pp.129-136, 2008./
|
|